Cargando…
Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI
Glioblastoma (GBM) is a malignant tumor. The long-term prognosis of the patients is poor. Therefore, it is of important clinical value to further explore the pathogenesis and look for molecular markers for early diagnosis and targeted treatment. Two expression profiling datasets [GSE50161 (GPL570 pl...
Autores principales: | Zhang, Shuyuan, Zhang, Weiwei, Wu, Bin, Xia, Liang, Li, Liwen, Jin, Kai, Zou, Yangfan, Sun, Caixing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666166/ https://www.ncbi.nlm.nih.gov/pubmed/36397358 http://dx.doi.org/10.1097/MD.0000000000031418 |
Ejemplares similares
-
Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis
por: Xu, Baowei
Publicado: (2021) -
Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway
por: Xia, Liang, et al.
Publicado: (2022) -
Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology
por: Cui, Kai, et al.
Publicado: (2021) -
Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
por: Li, Haowen, et al.
Publicado: (2023) -
Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma
por: Dai, Dongjun, et al.
Publicado: (2020)